Table 4. Relationship between clinical parameters, MEX3A mRNA expression and relapse-free survival in liver cancer patients.

	Univariate analysis			Multivariate analysis
Parameters	Hazard ratio	95%CI (lower∼upper)	P value	Hazard Ratio	95%CI (lower–upper)	P value
Age	0.90	0.63–1.28	0.550
Gender	0.99	0.7–1.41	0.966
Histological type	2.02	0.66–6.24	0.220
Histologic grade	0.98	0.8–1.21	0.883
Stage	1.66	1.38–1.99	0.000	1.13	0.87–1.46	0.358
T classification	1.78	1.49–2.12	0.000	1.69	1.29–2.21	0.000
N classification	0.97	0.67–1.4	0.874
M classification	1.17	0.79–1.74	0.432
Radiation therapy	0.74	0.26–2.16	0.584
Residual tumor	1.28	1.01–1.61	0.042	1.32	1.04–1.67	0.024
MEX3A	2.05	1.46–2.9	0.000	2.19	1.54–3.12	0.000

Notes.

P-value in bold represent significant clinical significance (p < 0.05).